Aprea Therapeutics, Inc.

APRE · XNAS

CIK 1781983fmd_04PHGD8571KE6508WBP4J065TGManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2017 to Sep 30, 2026, 35 periods

Loading

FinancialMD terminal